FlandersBio on Twitter

Complix to Present at Upcoming BioEquity Europe 2013: http://t.co/jzPUX0k7Bp

Follow us on Twitter

News

Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

QUINVITA announces successful closure of EUR 1.5 million capital round

23/04/2012

QUINVITA, the Industrial Crop Technology Company today announced the closure of its capital round, raising EUR 1.5 million from a group of investors including Think2Act Arkiv, Group Vanden Avenne Izegem and a number of private investors.

“The financial support of the investors will allow QUINVITA to further develop its proprietary game changing F1 hybrids. The proceeds and the industrial knowledge of Group Vanden Avenne Izegem will also allow an aggressive business development of commercial F1 hybrids and the proprietary animal feed technology QUINVITA acquired. The injection of these proprietary QUINVITA technology elements into Jatropha curcas emerging markets will bring professional Jatropha projects faster to a very significant profitability” said Henk Joos, the CEO of QUINVITA. “It is unique that an investment in a technology company like QUINVITA can form such a formidable catalyzer for a global emerging new crop. With the successful development of these proprietary technologies, Jatropha is set to become the second most productive oil crop in the world.”

Jo Breesch, managing partner of Think2Act, is pleased with the opportunity to invest in QUINVITA: “We are investing in a company that combines a novel business model, a market leadership position and an experienced management team. We are aware of the fact that Jatropha curcas is still an emerging crop. This creates the opportunity to have an impact on the developing business model.”

QUINVITA is one of the global market leaders in the science and development of Jatropha curcas as a sustainable bio-energy crop. Over the years it has developed a unique knowledge base in Jatropha genetics, agronomy and processing and is one of the few companies in the world with a combination of seeds, technology and knowledge that is readily available for practical implementation in Jatropha plantations. QUINVITA has a broader knowledge base on other novel industrial crops and on traditional agricultural crops based on the collective experience of the QUINVITA management. QUINVITA recently acquired proprietary technology that allows the extraction of animal feed proof Jatropha kernel meal.

Think2Act Arkiv is a private equity fund with a focus on growth and innovative business models.

Source: QUINVITA

Tags: financing

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top

Print